TIRF
TIRF REMS Changes Leads to Issues With Prescriber Recertification
Changes to the Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl products has ...
MAY 3, 2021
FDA Advisory Committees See ‘Red Flags’ in TIRF REMS
A FDA advisory committee raised concerns with the TIRF REMS program after reviewing data during a recent public ...
AUGUST 7, 2018
DEA Begins Targeting Off-Label Prescribing of TIRF Products
Traditionally, the decision whether to prescribe a certain medication off-label or not is reserved for the ...
OCTOBER 23, 2017
New Jersey Under Fire for Selective Scrutiny of Fentanyl Sublingual Spray
When the state of New Jersey decided to target physicians prescribing fentanyl sublingual spray (Subsys, INSYS ...
MAY 9, 2017
Load more